BIOGAZELLE (CellCarta)
Company Snapshot
Founded: 2019
Entity Type: Private
Region: Canada
Headquarter: Quebec, Canada
Key Geographics: North America, Europe, Australia, Asia
Corporate Address: 201 President Kennedy Avenue Suite 3900, Montreal Quebec, Canada H2X 3Y7 Tel. +1-(514)-360-3600 www.cellcarta.com
Company Overview
Biogazelle is developing RNA-based diagnostics that use qPCR technologies. The company is active in discovering and using liquid biopsy RNA biomarkers.
For liquid biopsy, Biogazelle markets a range of targeted tests that can be applied on cell-free or circulating DNA for detecting and quantifying specific genomic aberrations. Biomarkers emphasized include messenger RNA, microRNA and long non-coding RNA.
Company's Business Segments
- RNA Profiling : The company provides RNA profiling information using next-generation sequencing (NGS) with the appropriate platforms to tackle any sequencing project size (NovaSeq X Plus, NovaSeq 6000, NextSeq 550Dx). It also offers access to a broad range of biomarker platforms and services.
Applications/End User Industries
- Healthcare
- Biopharmaceutical
